Thomas J. Schall, Director at Immuneering Corp (IMRX), bought 9,500 shares at $3.66 ($35K) on 2025-06-27, disclosed to the SEC on 2025-06-30.
Open-market purchase of $35k IMRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| IMRX | BUY | 2024-03-25 | $7K | — | Filing → |
| CCXI | SELL | 2022-08-08 | $6.5M | — | Filing → |
| CCXI | SELL | 2020-12-16 | $3.7M | — | Filing → |